Introduction
============

Of patients with advanced chronic obstructive pulmonary disease (COPD), approximately 94% report breathlessness and 40% report pain.[@b1-copd-7-137] In the palliative phases of COPD, prevalence rates for breathlessness increase to 95%--98% and for pain to 68%--72%.[@b2-copd-7-137],[@b3-copd-7-137] While both of these symptoms are common in COPD, only six studies have investigated these two symptoms in the same patients.[@b1-copd-7-137]--[@b6-copd-7-137]

Pain has long been recognized as a symptom that includes a variety of sensations and multiple dimensions.[@b7-copd-7-137] Breathlessness is described as a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity. [@b8-copd-7-137] Only recently, though, was the multidimensional model of pain applied to the symptom of breathlessness.[@b9-copd-7-137] In that paper, Lansing et al illustrated how breathlessness is a multidimensional construct, similar to pain, which consists of at least three separate and distinct qualities, namely "air hunger", "work", and "tightness".[@b9-copd-7-137] "Air hunger" is the perception of the urge to breath. This fundamental biological drive arises when pulmonary ventilation is insufficient. "Work" is perceived as being uncomfortable when the work of breathing is increased by high ventilation, by increasing resistance to inspiration, weakness of respiratory muscles, or shortened inspiratory muscle length. "Tightness" appears to be associated with bronchoconstriction.[@b9-copd-7-137],[@b10-copd-7-137] Taken together, in patients with COPD, bronchoconstriction, airflow limitations, decreased ventilation, and hyperinflation may give rise to the sensations of air hunger, increased work of breathing and tightness.[@b9-copd-7-137],[@b10-copd-7-137]

Breathlessness and pain may share common neurophysiological pathways.[@b9-copd-7-137] Recent evidence suggests that the anterior insula is a critical structure involved in the perception of the emotional aspects of breathlessness and pain. Within this paradigm, pain is viewed as a part of the arousal/stress system that is characterized by increased sympathetic activation, which results in an increased respiratory rate.[@b9-copd-7-137] In a recent study of patients with fibromyalgia,[@b11-copd-7-137] patients who were taught slow breathing reported decreases in pain intensity.[@b11-copd-7-137] Of note, the use of slow breathing had a greater effect on moderate pain than on mild pain.[@b11-copd-7-137] This finding suggests that breathing rate influences pain intensity.[@b9-copd-7-137],[@b11-copd-7-137]

While information on the relationship between pain intensity and breathlessness is increasing, little is known about the relationships between these two symptoms in patients with COPD. In one study that evaluated a number of respiratory parameters and pain in patients with COPD,[@b5-copd-7-137] increases in self-reported breathlessness were associated with increases in pain (*r* = −0.22, *P* \< 0.05). In addition, decreases in oxygen saturation were associated with increased pain (*r* = 0.23, *P* \< 0.05).[@b5-copd-7-137] In a more recent study,[@b6-copd-7-137] while no associations were found between objective measures of lung function and pain intensity, increased breathlessness was associated with increased pain intensity (*r* = 0.26, *P* \< 0.01).

Given the paucity of research on the associations between pain and breathlessness in patients with COPD, the purposes of this study were to evaluate for differences in subjective (ie, breathlessness) and objective (ie, lung function) respiratory parameters between COPD patients who did and did not have pain, and to evaluate which subjective and objective respiratory variables provided unique contributions to explain the likelihood of being classified in the pain group at the time of enrollment into a pulmonary rehabilitation program.

Methods
=======

Design, sample, and data collection
-----------------------------------

This cross-sectional study enrolled 136 patients with COPD who were recruited between August 2005 and August 2007 prior to enrollment in a pulmonary rehabilitation program. Patients were included if they were: \>35 years of age; diagnosed with COPD by a pulmonary physician; reported symptoms of breathlessness, chronic cough, and sputum production; had a FEV~1~/FVC \< 70% and FEV~1~ \< 80% predicted; and were able to read and write Norwegian. The exclusion criteria for the study were using long-term oxygen treatment and unstable heart disease.

Patients were approached in the outpatient clinic and were given verbal and written information about the study. Patients who were willing to participate signed the informed consent and underwent spirometry. In addition, all patients were asked to complete a number of self-report questionnaires and to return them in a postage paid envelope. After 2 weeks, a reminder letter was sent to those who had not returned the questionnaires. The study was approved by the hospital unit, the Regional Committee for Medical Research Ethics, and the Norwegian Social Science Data Services.

Instruments
===========

Demographic characteristics
---------------------------

Patients completed a demographic questionnaire that obtained information on age (continuous variable in years), sex (male, female), education (primary school, secondary school, and university), marital status (married/partnered, unmarried, widowed, divorced/separated), employment status (full or part time, not employed), smoking (current smoker, previous smoker, never smoked), comorbidities (yes, no), and other chronic medical conditions (myocardial infarction, angina, stroke, diabetes, cancer, osteoporosis, fibromyalgia, chronic pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, skeletal/muscle diseases, psychiatric diagnosis, gastrointestinal disease, asthma).

Lung function
-------------

Spirometry was performed with a Vitalograph Alpha spirometer (Vitalograph Alpha, Lenexa, KS), according to published guidelines.[@b12-copd-7-137] Forced expiratory volume in one second (FEV~1~) and forced vital capacity (FVC) were measured and the predicted values calculated according to a Norwegian reference population.[@b13-copd-7-137] FEV~1~ (L) and FEV~1~ as a percentage of the predicted value (predicted FEV~1~%) were used as a measure of lung function.

Disease severity
----------------

Disease severity was classified using the Global Initiative for COPD (GOLD) criteria: mild, moderate, severe, and very severe COPD, defined as FEV~1~/FVC \< 0.7, FEV~1~ ≥ 80% predicted, FEV~1~ 50%--80% predicted, FEV~1~ 50%--30% predicted, or FEV~1~ \< 30% predicted, respectively.[@b14-copd-7-137]

Breathlessness
--------------

Breathlessness was measured with the St George's Respiratory Questionnaire (SGRQ).[@b15-copd-7-137] SGRQ is a disease-specific questionnaire that measures health status for patients with pulmonary disease. The questionnaire consists of 76 items divided into three components: symptoms, activity, and impact. A sum is calculated for each component. Each of the component scores can range from 0 to 100, with lower scores indicating better health status.[@b16-copd-7-137]--[@b18-copd-7-137] The SGRQ has been translated into different languages and has satisfactory reliability and validity in COPD patients.[@b19-copd-7-137]--[@b21-copd-7-137] As was done in previous studies,[@b15-copd-7-137],[@b18-copd-7-137] the symptom component score was used as the measure of breathlessness. The symptom component consists of eight items, including frequency and distress from breathlessness in terms of phlegm/sputum, shortness of breath, wheezing, and chest trouble.[@b15-copd-7-137],[@b18-copd-7-137] In addition, the following individual breathlessness items were evaluated: my cough hurts; my cough makes me tired; I get breathless when I bend over; my cough or breathing disturbs my sleep; and I get exhausted easily. Each item was scored using the 0 (wrong) versus 1 (right) format. The symptom component score, as well as the individual item scores, were used to evaluate differences in cough and breathlessness in COPD patients with and without pain.

Pain
----

Patients were categorized into the pain versus no pain groups based on their responses to the following question: "Are you generally bothered by pain?"

Statistical analyses
--------------------

Data were analyzed using SPSS (v16.0; SPSS Inc, Chicago, IL). Descriptive statistics were used to evaluate demographic, clinical, respiratory, and pain variables. Chi-square and independent sample *t*-tests were used to evaluate for differences in demographic and clinical characteristics, and respiratory parameters between COPD patients who did and did not have pain. Multiple logistic regression analysis was done to evaluate the impact of specific respiratory parameters (ie, breathlessness and lung function) on pain status (ie, having or not having pain) after controlling for clinical characteristics (ie, number of comorbidities) that showed significant bivariates association with pain. Model fit was assessed using the Hosmer and Lemeshow test. A *P*-value of \<0.05 was considered statistically significant.

Results
=======

Of the 136 patients who met the inclusion criteria, 100 accepted the invitation to participate in this study (response rate of 74%). No differences were found in the age (*P* = 0.60) or sex distribution (*P* = 0.92) of the patients who did and did not participate in this study. Of the 100 COPD patients who participated in the study, 45% responded "yes" to the question "Are you generally bothered by pain?"

Differences in demographic and clinical characteristics between COPD patients who did and did not have pain
-----------------------------------------------------------------------------------------------------------

As shown in [Table 1](#t1-copd-7-137){ref-type="table"}, no significant differences were found in any demographic characteristics between COPD patients who did and did not have pain. As shown in [Table 2](#t2-copd-7-137){ref-type="table"}, compared to patients without pain, COPD patients with pain were more likely to report the presence of a comorbidity (*P* = 0.016); had a significantly higher number of comorbidities (*P* \< 0.001); and reported a higher breathlessness score on SGRQ (*P* = 0.003). In terms of self-reported occurrence of chronic medical conditions (see [Table 3](#t3-copd-7-137){ref-type="table"}), a higher percentage of COPD patients with pain reported chronic pain (22%; *P* \< 0.001) and musculoskeletal diseases (24%; *P* = 0.003) compared to those who did not have pain.

Differences in breathlessness between COPD patients who did and did not have pain
---------------------------------------------------------------------------------

As shown in [Figure 1](#f1-copd-7-137){ref-type="fig"}, a significantly higher percentage of patients who had pain endorsed the following breathlessness items: "my cough makes me hurt" (*P* = 0.004); "my cough makes me tired" (*P* = 0.006); "my cough or breathing disturbs my sleep" (*P* = 0.001); and "I get exhausted easily" (*P* = 0.027).

Impact of selected variables on pain in COPD patients
-----------------------------------------------------

As shown in [Table 4](#t4-copd-7-137){ref-type="table"}, based on the results of the logistic regression analysis, after adjusting for the number of comorbidities (OR = 0.28; *P* = 0.026), greater breathlessness measured by the SGRQ symptom score (OR = 1.03; *P* = 0.003) was significantly associated with pain, while lung function (OR = 1.03; *P* = 0.052) was nearly significant. The model fit showed that number of comorbidities, breathlessness and lung function explained 23% (Nagelkerke R-square) of the variability in pain. The Hosmer and Lemeshow test statistic indicated that goodness of fit to the model was satisfactory.

Discussion
==========

This study is the first to evaluate for differences in subjective and objective respiratory parameters in COPD patients with or without pain. It is interesting that after adjusting for the number of comorbidities, the COPD patients with pain reported significantly higher breathlessness scores compared to those who did not report pain. In contrast, similar associations were not found for pain and the objective measure of lung function. These findings are consistent with two previous reports that used similar measures.[@b5-copd-7-137],[@b6-copd-7-137] In addition, findings across these quantitative studies are consistent with a recent qualitative study of COPD patients who were interviewed about their pain experiences. Some of these patients described their pain as "tying up the body," which makes it impossible to breathe normally and in turn resulted in increased pain.[@b4-copd-7-137] A growing body of evidence suggests that these distinctly different sensations share important characteristics. The relationship between pain and breathlessness may be partially explained by the fact that these sensations are mediated within a larger brain network in the anterior insula. Both sensations alert the brain and motivate adaptive behaviors.[@b9-copd-7-137] Additional research is warranted to examine the commonalities and differences in these two sensations.

In this study, a significantly higher percentage of COPD patients with pain reported that their cough made them hurt, that their cough made them tired, that breathlessness/cough disturbed their sleep, and that they became exhausted easily. These findings are consistent with a study by Williams and colleagues,[@b22-copd-7-137] which found that patients with COPD reported that breathlessness was painful, made them tired and weak, and led to general exhaustion. Again, the association between these respiratory descriptors and pain provide additional evidence that breathlessness and pain may share more than common cortical pathways.[@b9-copd-7-137] Pain is a complex symptom that is caused by many different bodily changes.[@b23-copd-7-137] COPD is a complex progressive lung disease. As the disease progresses, elastic tissues in the lung are damaged, which leads to increased mucous hypersecretion, cough, airway narrowing, decreased oxygen saturation, and breathlessness.[@b14-copd-7-137] These pathophysiologic changes may lead to pain, sleeplessness, fatigue, and exhaustion.[@b4-copd-7-137] The disease progresses the airflow limitations and decreases in ventilation may increase respiratory muscle work and the work of breathing[@b24-copd-7-137],[@b25-copd-7-137] which in turn may result in fatigue, exhaustion, and pain.[@b4-copd-7-137] An equally plausible hypothesis is that breathlessness and increased muscle work may lead to muscle hypertonicity and fatigue, which in turn results in increased ventilatory drive associated with greater breathlessness.[@b4-copd-7-137],[@b10-copd-7-137] A third hypothesis to explain the associations between cough, breathlessness, and pain in COPD patients is that coughing can lead to pain for mechanical reasons and results in fatigue because it requires energy.[@b4-copd-7-137],[@b10-copd-7-137] All of these hypotheses warrant testing in future studies.

Of note, those COPD patients who had pain reported a significantly higher number of comorbidities than those who did not have pain. In addition, a higher percentage of COPD patients with pain reported the occurrence of chronic pain and musculoskeletal disorders. As is seen in patients with other chronic medical conditions,[@b26-copd-7-137],[@b27-copd-7-137] patients with COPD may have pain associated with COPD, pain associated with other chronic medical conditions, and/or pain associated with both their COPD and other chronic medical conditions. Additional research is warranted to determine the specific and/or multiple etiologies for pain in patients with COPD.

A surprising finding was that no differences were found in any demographic characteristics (eg, age, sex, education, marital status, employment status) between COPD patients with and without pain. These findings differ from a previous study of pain in the general Norwegian population,[@b28-copd-7-137] which found that being younger, being female, having less formal education, living alone, and being unemployed were associated with chronic pain. The reasons for these differences are not readily apparent and warrant investigation in future studies.

Several study limitations need to be acknowledged. Because of the relatively small sample size, additional differences in both subjective and objective respiratory parameters between COPD patients with and without pain warrant investigation in future studies. According to the biopsychosocial model, pain is associated with physiologic as well as psychosocial factors.[@b29-copd-7-137]--[@b31-copd-7-137] Therefore, future studies with larger samples may determine additional demographic and sociocultural characteristics associated with pain group membership. Finally, the COPD patients in this study were about to begin a pulmonary rehabilitation program. Therefore, this sample that consisted of patients who had primarily moderate to severe COPD, is not a representative sample of all COPD patients.

Despite the low sample size in this study, breathlessness is associated with pain, which indicates that increased breathlessness may result in pain. By striving for greater understanding of the relationship between breathlessness and pain, the authors suggest that there should be a stronger focus on the relationship between breathlessness and pain when precise and effective COPD interventions are planned.

Conclusion
==========

In conclusion, the findings from this study suggest that pain is a significant problem in patients with COPD. In addition, COPD patients who had pain reported a higher number of comorbidities and breathlessness than COPD patients who did not have pain. Additional research is warranted to more completely characterize the causes and multiple dimensions of the pain experience of patients with COPD during various stages of their disease and treatment. A stronger focus on the relationship between breathlessness and pain when precise and effective COPD interventions are planned is recommended.
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![Differences in the percentages of patients with chronic obstructive pulmonary disease (COPD) who did (N = 45) and did not (N = 55) have pain who endorsed each of the breathlessness items on the St George's Respiratory Questionnaire.](copd-7-137f1){#f1-copd-7-137}

###### 

Differences in demographic characteristics between patients with chronic obstructive pulmonary disease who did (N = 45) and did not (N = 55) have pain

  Demographics          COPD patients with pain (N = 45)   COPD patients without pain (N = 55)   *P*-value                            
  --------------------- ---------------------------------- ------------------------------------- ----------- ------- ------- -------- ------
  Age (years)           65.0                               9.2                                   43--83      67.9    7.3     50--80   0.08
                        **N**                              **%**                                             **N**   **%**            
                                                                                                                                      
  Sex                                                                                                                                 0.55
   Male                 21                                 47                                                30      55               
   Female               24                                 53                                                25      45               
  Education                                                                                                                           0.71
   Primary school       24                                 53                                                25      46               
   Secondary school     17                                 38                                                22      41               
   University           4                                  9                                                 7       13               
  Marital status                                                                                                                      0.91
   Married/partners     28                                 64                                                37      68               
   Unmarried            2                                  4                                                 2       4                
   Widow                6                                  14                                                8       15               
   Divorced/separated   8                                  18                                                7       13               
  Employment status                                                                                                                   0.36
   Full or part time    13                                 29                                                11      20               
   Not employed         32                                 71                                                43      80               

**Abbreviation:** COPD, chronic obstructive pulmonary disease.

###### 

Differences in clinical characteristics between patients with COPD who did (N = 45) and did not (N = 55) have pain

  Characteristics                     COPD patients with pain (N = 45)   COPD patients without pain (N = 55)   *P*-value                               
  ----------------------------------- ---------------------------------- ------------------------------------- ----------- ------- ------- ----------- -------------
  Number of comorbidities             2.6                                1.9                                   7--15       1.0     0.87    0--15       \<**0.001**
  Pack years                          39.6                               29.5                                  3--140      33.4    20.3    0--100      0.24
  Lung function (FEV~1~% predicted)   47.8                               15.8                                  19--79      44.5    14.3    16--79      0.27
  Breathlessness (SGRQ) (0--100)      58.9                               25.4                                  9.8--97.5   42.4    27.7    0.0--93.9   **0.003**
                                      **N**                              **%**                                             **N**   **%**               
                                                                                                                                                       
  Comorbidity                                                                                                                                          **0.016**
   Yes                                40                                 89                                                36      67                  
   No                                 5                                  11                                                18      33                  
  Smoking                                                                                                                                              0.24
   Current smoker                     18                                 44                                                13      27                  
   Previous smoker                    23                                 56                                                35      71                  
   Never smoked                       0                                  0                                                 1       2                   
  Disease severity                                                                                                                                     0.09
   Moderate                           24                                 53                                                20      36                  
   Severe                             14                                 31                                                29      53                  
   Very severe                        7                                  16                                                6       11                  

**Abbreviations:** COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in 1 second; SGRQ, St George's Respiratory Questionnaire.

###### 

Comparison of prevalence of various comorbid conditions between patients with COPD who did (N = 45) and did not (N = 55) have pain

  Conditions                 COPD patients with pain (N = 45)   COPD patients without pain (N = 55)   *P*-values        
  -------------------------- ---------------------------------- ------------------------------------- ------------ ---- -------------
  Myocardial infarction      15                                 33                                    9            17   0.06
  Angina                     9                                  20                                    7            13   0.42
  Stroke                     3                                  7                                     0            0    0.09
  Diabetes                   6                                  13                                    4            7    0.51
  Cancer                     7                                  16                                    2            4    0.08
  Osteoporosis               7                                  16                                    2            4    0.08
  Fibromyalgia               3                                  7                                     0            0    0.09
  Chronic pain               10                                 22                                    0            0    \<**0.001**
  Rheumatoid arthritis       1                                  2                                     0            0    0.46
  Osteoarthritis             10                                 22                                    4            7    0.05
  Ankylosing spondylitis     1                                  2                                     0            0    0.46
  Skeletal/muscle diseases   11                                 24                                    2            4    **0.003**
  Psychiatric diagnosis      5                                  11                                    4            7    0.73
  Gastrointestinal disease   7                                  16                                    4            7    0.22
  Asthma                     20                                 46                                    14           28   0.09

**Abbreviation:** COPD, chronic obstructive pulmonary disease.

###### 

Risk factors of pain in patients with chronic obstructive pulmonary disease assessed by multiple logistic regression analysis (N = 99)

                                      B       OR     95% CI       *P*-values
  ----------------------------------- ------- ------ ------------ ------------
  Number of comorbidities             −1.13   0.28   0.09--0.86   **0.026**
  Breathlessness (SGRQ, 0--100)^a^    0.03    1.03   1.01--1.05   **0.003**
  Lung function (FEV~1~% predicted)   0.03    1.03   1.00--1.06   0.052

**Notes:** The corresponding logistic regression model fitted to these data using Hosmer and Lemeshow Test. Regression coefficients (B), Adjusted odds ratios (OR) (95% confidence interval), and *P*-values.

**Abbreviations:** COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in 1 second; SGRQ, St George's Respiratory Questionnaire.
